{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:28:10Z","timestamp":1791404890279,"version":"4.3.3"},"update-to":[{"DOI":"10.1002\/14651858.cd005552.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000}}],"reference-count":123,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005552.pub3","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T05:04:12Z","timestamp":1597381452000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome"],"prefix":"10.1002","volume":"2020","author":[{"given":"Eloise","family":"Fraison","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics; H\u00f4pital Femme M\u00e8re Enfant; Bron France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Kostova","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine; Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa J","family":"Moran","sequence":"additional","affiliation":[{"name":"Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine; Monash University; Clayton Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Bilal","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology; Westmead Hospital; Westmead Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn C","family":"Ee","sequence":"additional","affiliation":[{"name":"NICM Health Research Institute; Western Sydney University; Penrith Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Venetis","sequence":"additional","affiliation":[{"name":"Centre for Big Data Research in Health & School of Women's & Children's Health; UNSW Medicine; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F","family":"Costello","sequence":"additional","affiliation":[{"name":"Division of Obstetrics & Gynaecology; School of Women's and Children's Health, UNSW and Royal Hospital for Women and IVF Australia; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD005552.pub3-BIB0001|cit1","first-page":"347","article-title":"Comparison of metformin and cyproterone-estrodiol compound effect on HS C-reactive protein and serum androgen levels in patients with polycystic ovary syndrome","volume":"26","author":"Aghamohammadzadeh","year":"2010","journal-title":"Pakistan Journal of Medical Science"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1515\/JPEM.2005.18.8.761","article-title":"Randomized controlled trial evaluating response to Metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome","volume":"18","author":"Allen","year":"2005","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1515\/jpem-2014-0283","article-title":"Randomized clinical trial evaluating Metformin versus oral contraceptive pills in the treatment of adolescents with polycystic ovarian syndrome","volume":"28","author":"Al-Zubeidi","year":"2015","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0004|cit4","doi-asserted-by":"crossref","unstructured":"Bhattacharya S M Biswas B Basu A Comparative study of the therapeutic effects of drospirenone (DRSP, 3mg) with ethinyl estradiol (EE, 20 mcg) pill with or without metformin 500 mg in polycystic ovary syndrome (PCOS) Fertility and Sterility e257","DOI":"10.1016\/j.fertnstert.2016.07.740"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.tjog.2018.04.015","article-title":"The effects of different therapeutic modalities on cardiovascular risk factors in women with polycystic ovary syndrome: a randomized controlled study","volume":"57","author":"Bodur","year":"2018","journal-title":"Taiwanese Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/TEN.0b013e3181a58772","article-title":"The effects of rosiglitazone, metformin, and estradiol-cyproterone acetate on lean patients with polycystic ovary syndrome","volume":"19","author":"Cetinkalp","year":"2009","journal-title":"Endocrinologist"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0007|cit7","first-page":"488","article-title":"The benefit-to-risk ratio of common treatments in PCOS: effect of oral contraceptives versus metformin on atherogenic markers","volume":"13","author":"Christakou","year":"2014","journal-title":"Hormones"},{"issue":"1","key":"10.1002\/14651858.CD005552.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/humrep\/deh588","article-title":"The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients","volume":"20","author":"Cibula","year":"2005","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1055\/s-0033-1363261","article-title":"Effects of metformin or an oral contraceptive containing cyproterone acetate on serum C-reactive protein, Interleukine-6 and Soluble Vascular Cell Adhesion Molecule-1 concentrations in women with polycystic ovary syndrome","volume":"122","author":"Dardzinska","year":"2014","journal-title":"Experimental and Clinical Endocrinology & Diabetes"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.mefs.2014.10.003","article-title":"Randomized controlled trial of the effects of metformin versus combined oral contraceptives in adolescent PCOS women through a 24 months follow up period","volume":"20","author":"El Maghraby","year":"2015","journal-title":"Middle East Fertility Society Journal"},{"issue":"7","key":"10.1002\/14651858.CD005552.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/humrep\/17.7.1729","article-title":"Clinical, endocrine and metabolic effects of metformin added to ethinyl-estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study","volume":"17","author":"Elter","year":"2002","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD005552.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.fertnstert.2011.05.091","article-title":"Effect of combined metformin and oral contraceptive therapy on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndrome","volume":"96","author":"Essah","year":"2011","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD005552.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/09513590.2015.1101441","article-title":"Management of polycystic ovarian syndrome with Diane-35 or Diane-35 plus metformin","volume":"32","author":"Feng","year":"2016","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0014|cit14","first-page":"2584","article-title":"Body composition is improved during 12 month's treatment with Metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome","volume":"99","author":"Glintborg","year":"2014","journal-title":"Endocrine Research"},{"issue":"9","key":"10.1002\/14651858.CD005552.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1210\/jc.2003-030424","article-title":"Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome","volume":"88","author":"Harborne","year":"2003","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1210\/jc.2008-0461","article-title":"The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials","volume":"93","author":"Hoeger","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1210\/jc.2008-0461","article-title":"The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials","volume":"93","author":"Hoeger","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0018|cit18","first-page":"10","article-title":"The effect of combination therapy with Metformin and combined Cyproterone Acetate\/ Ethinyl Estradiol in PCOS patients","volume":"29","author":"Jin","year":"2006","journal-title":"Chinese Journal of Postgraduate Medicine"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/09513590.2015.1006188","article-title":"Metformin improves endothelial function and carotid intima media thickness in patients with PCOS","volume":"31","author":"Kaya","year":"2015","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00404-009-1051-y","article-title":"Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome","volume":"281","author":"Kebapcilar","year":"2009","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2169\/internalmedicine.48.2177","article-title":"The effect of ethinylestradiol (EE)\/cyproterone acetate (CA) and EE\/CA plus metformin treatment on adhesion molecules in cases with polycystic ovary syndrome (PCOS)","volume":"48","author":"Bilgir","year":"2009","journal-title":"International Medicine"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0022|cit22","first-page":"423","article-title":"Effects of an EE\/CA compared with EE\/CA-metformin on serum ADMA levels in women with polycystic ovary syndrome","volume":"4","author":"Kebapcilar","year":"2009","journal-title":"Central European Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD005552.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3109\/09513590.2010.530706","article-title":"Inflammatory-metabolic parameters in obese and nonobese normoandrogenemic polycystic ovary syndrome during metformin and oral contraceptive treatment","volume":"27","author":"Kilic","year":"2011","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3736\/jcim20110907","article-title":"Efficacy of chinese patent medicine Tian Gui Capsule in patients with polycystic ovary syndrome: a randomized controlled trial","volume":"9","author":"Kuek","year":"2011","journal-title":"Journal of Chinese Integrative Medicine"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4103\/jfmpc.jfmpc_83_17","article-title":"A randomized, controlled trial comparing the metformin, oral contraceptive pills and their combination in patients with polycystic ovarian syndrome","volume":"7","author":"Kumar","year":"2018","journal-title":"Journal of Family Medicine and Primary Care"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0026|cit26","first-page":"530","article-title":"The effect of combination therapy with Metformin and combined Cyproterone Acetate\/Ethynil Estradiol on PCOS patients","volume":"19","author":"Liu","year":"2006","journal-title":"Chinese Journal of Postgraduate Medicine"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jc.2007-0282","article-title":"Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with polycystic ovary syndrome","volume":"92","author":"Luque-Ramirez","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.2337\/dc07-0642","article-title":"Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses","volume":"30","author":"Luque-Ramirez","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/humrep\/den095","article-title":"Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin","volume":"23","author":"Luque-Ramirez","year":"2008","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.fertnstert.2008.03.082","article-title":"Effects of Metformin versus Ethinyl-estradiol plus cyproterone acetate on ambulatory blood pressure monitoring and carotid intima media thickness in women with the polycystic ovary syndrome","volume":"91","author":"Luque-Ramirez","year":"2008","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/BF02873575","article-title":"Effects of Metformin combined with cyproterone acetate on clinical features, endocrine and metabolism of non-obese women with polycystic ovarian syndrome","volume":"25","author":"Lv","year":"2005","journal-title":"Journal of Huazhong University of Science and Technology"},{"issue":"3","key":"10.1002\/14651858.CD005552.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2337\/dc06-0618","article-title":"Effect of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome","volume":"30","author":"Meyer","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0033|cit33","first-page":"S95","article-title":"A comparative study to illustrate the benefits of using ethinyl estradiol-cyproterone acetate over metformin in patients with polycystic ovarian syndrome","volume":"10S","author":"Mhao","year":"2015","journal-title":"Diabetes and Metabolic Syndrome: Clinical Research and Reviews"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/BF03345790","article-title":"Novel inflammatory markers in overweight women with or without polycystic ovary syndrome and following pharmacological intervention","volume":"33","author":"Moran","year":"2010","journal-title":"Journal of Endocrinological Investigation"},{"issue":"9","key":"10.1002\/14651858.CD005552.pub3-BIB0035|cit35","first-page":"3161","article-title":"Endocrine and metabolic effects of metformin versus ethinyl-estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study","volume":"85","author":"Morin-Papunen","year":"2000","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD005552.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2002-020997","article-title":"Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study","volume":"88","author":"Morin-Papunen","year":"2003","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"12","key":"10.1002\/14651858.CD005552.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1177\/1933719113488444","article-title":"Effects of drospirenone-ethinylestradiol and\/or metformin on CD4+ CD28 null T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial","volume":"20","author":"Moro","year":"2013","journal-title":"Reproductive Science"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.atherosclerosis.2007.12.054","article-title":"Metformin and oral contraceptive treatment reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS)","volume":"200","author":"Ozgurtas","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.1.01840","article-title":"Effects of metformin and ethinyl-estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome","volume":"152","author":"Rautio","year":"2005","journal-title":"European Journal of Endocrinology"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00404-018-4762-0","article-title":"Effect of Diane-35, alone or in combination with orlistat or metformin in Chinese polycystic ovary syndrome patients","volume":"297","author":"Ruan","year":"2018","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"5","key":"10.1002\/14651858.CD005552.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jogoh.2018.10.006","article-title":"Doppler analysis of ovarian stromal blood flow changes after treatment with metformin versus ethinyl estradiol-cyproterone acetate in women with polycystic ovarian syndrome: a randomized controlled trial","volume":"48","author":"Sahu","year":"2018","journal-title":"Journal of Gynecology Obstetrics and Human Reproduction"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/09513590.2017.1407752","article-title":"Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance","volume":"34","author":"Song","year":"2018","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0043|cit43","first-page":"405","article-title":"Evaluation of clinical efficacy of Metformin in treating polycystic ovary syndrome","volume":"41","author":"Teng","year":"2007","journal-title":"Journal of Harbin Medical University"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/EJE-11-0616","article-title":"A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome","volume":"166","author":"Wei","year":"2012","journal-title":"European Journal of Endocrinology"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/09513590802217027","article-title":"Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome","volume":"24","author":"Wu","year":"2008","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/EJE-17-0516","article-title":"Combined oral contraceptives plus spironolactone compared with Metformin in women with polycystic ovary syndrome: a one-year randomized clinical trial","volume":"177","author":"Alpanes","year":"2017","journal-title":"European Journal of Endocrinology"},{"issue":"10","key":"10.1002\/14651858.CD005552.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1080\/09513590.2018.1460343","article-title":"Effect of 12-months treatment with metformin and\/or oral contraceptives on health-related quality of life in polycystic ovary syndrome","volume":"34","author":"Altinok","year":"2018","journal-title":"Gynecological Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD005552.pub3-BIB0048|cit48","first-page":"347","article-title":"Identifying risk factors and screening tests for extent of metabolic risk in urban adolescent girls in a developing nation","volume":"9","author":"Bachani","year":"2016","journal-title":"International journal of child and adolescent health"},{"issue":"4","key":"10.1002\/14651858.CD005552.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.fertnstert.2012.06.035","article-title":"Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome","volume":"98","author":"Battacharya","year":"2012","journal-title":"Fertility and sterility"},{"issue":"2","key":"10.1002\/14651858.CD005552.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/cen.12028","article-title":"Impact of metformin monotherapy versus metformin with oestrogen-progesterone on lipids in adolescent girls with polycystic ovarian syndrome","volume":"79","author":"Bredella","year":"2013","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-0035-1564837","article-title":"Comprehensive assessment of the hemostatic system in polycystic ovarian syndrome","volume":"42","author":"Burchall","year":"2016","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00404-013-2742-y","article-title":"The effects of drospirenone-ethinyl estradiol and drospirenone-ethinyl estradiol + metformin on ovarian ultrasonographic markers, body fat mass index, leptin, and ghrelin","volume":"288","author":"Cakiroglu","year":"2013","journal-title":"Archive of Gynecology and Obstetrics"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.diabet.2015.10.004","article-title":"Effect of ethinylestradiol-cyproterone acetate vs. pioglitazone-flutamide-metformin on plasma FGF21 levels in adolescent girls with androgen excess","volume":"42","author":"Diaz","year":"2016","journal-title":"Diabetes and Metabolism"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s40618-014-0103-8","article-title":"Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-months randomized treatment with metformin and\/or contraceptives in polycystic ovary syndrome","volume":"37","author":"Glintborg","year":"2014","journal-title":"Journal of Endocrinal Investigation"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.metabol.2015.06.011","article-title":"Increased thrombin generation in women with polycystic ovary syndrome. A pilot study on the effect of metformin and oral contraceptives","volume":"64","author":"Glintborg","year":"2015","journal-title":"Metabolism"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1530\/EC-17-0034","article-title":"Effect of oral contraceptives and\/or metformin on GLP-1 secretion and reactive hypoglycemia in polycystic ovary syndrome","volume":"6","author":"Glintborg","year":"2017","journal-title":"Endocrine connections"},{"issue":"6","key":"10.1002\/14651858.CD005552.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1016\/j.fertnstert.2010.02.041","article-title":"Metformin, naltrexone, or the combination of prednisolone and antiandrogenic oral contraceptives as first-line therapy in hyperinsulinemic women with polycystic ovary syndrome","volume":"94","author":"Hadziomerovic-Pekic","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD005552.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.fertnstert.2009.08.006","article-title":"Improvement in quality of life questionnaire measures (PCOSQ) in obese adolescent females with PCOS treated with Lifestyle changes and oral contraceptives, with or without Metformin","volume":"93","author":"Harris-Glocker","year":"2009","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijgo.2009.08.004","article-title":"The role of family history in clinical symptoms and therapeutic outcomes of women with polycystic ovary syndrome","volume":"108","author":"Hu","year":"2010","journal-title":"International Journal of Gynecology and Obstetrics"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0060|cit60","first-page":"1427","article-title":"Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome","volume":"31","author":"Hutchison","year":"2008","journal-title":"Cardiovascular and Metabolic Risk"},{"issue":"12","key":"10.1002\/14651858.CD005552.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3109\/09513590.2010.487589","article-title":"Low-dose pioglitazone, flutamide, metformin plus an oestro-progestagen for non-obese young women with polycystic ovary syndrome: increasing efficacy and persistent safety over 30 months","volume":"26","author":"Ibanez","year":"2010","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jadohealth.2017.04.010","article-title":"Normalizing ovulation rate by preferential reduction of hepato-visceral fat in adolescent girls with polycystic ovary syndrome","volume":"61","author":"Ibanez","year":"2017","journal-title":"Journal of Adolescent Health"},{"issue":"2","key":"10.1002\/14651858.CD005552.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/09513590.2010.491164","article-title":"Metformin plus oral contraceptive may decrease plasma sCD40 ligand in women with PCOS patients","volume":"27","author":"Kebapcilar","year":"2010","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.fertnstert.2009.02.029","article-title":"Effects of pioglitazone on ovarian stromal blood flow, ovarian stimulation, and in vitro fertilization outcome in patients with polycystic ovary syndrome","volume":"94","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"8","key":"10.1002\/14651858.CD005552.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1016\/j.fertnstert.2011.05.048","article-title":"Effects of metformin in adolescents with polycystic ovary syndrome undertaking lifestyle therapy: a pilot randomized double-blind study","volume":"95","author":"Ladson","year":"2011","journal-title":"Fertility and Sterility"},{"issue":"11","key":"10.1002\/14651858.CD005552.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3109\/09513590.2011.569608","article-title":"Fatty acid-blinding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess","volume":"27","author":"Lazaro","year":"2011","journal-title":"Gynecological Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD005552.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/humrep\/dei312","article-title":"Rosiglitazone and ethinyl estradiol\/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance","volume":"21","author":"Lemay","year":"2006","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD005552.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/oby.2008.491","article-title":"Antiandrogenic contraceptives increase serum adiponectin in obese polycystic ovary syndrome patients","volume":"17","author":"Luque-Ramirez","year":"2008","journal-title":"Obesity"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1530\/EJE-08-0725","article-title":"Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking","volume":"160","author":"Luque-Ramirez","year":"2009","journal-title":"European Journal of Endocrinology"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1055\/s-0030-1262855","article-title":"Treatment of polycystic ovary syndrome (PCOS) with metformin ameliorates insulin resistance in parallel with decrease of serum interleukine-6 concentrations","volume":"42","author":"Luque-Ramirez","year":"2010","journal-title":"Hormone and Metabolic Research"},{"issue":"3","key":"10.1002\/14651858.CD005552.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1210\/jc.2010-2211","article-title":"Role of decreased circulating hepcidin concentrations in the iron excess of women with polycystic ovary syndrome","volume":"96","author":"Luque-Ramirez","year":"2011","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/1735-1995.177354","article-title":"Comparison of the effects of metformin, flutamide plus oral contraceptives, and simvastatin on the metabolic consequences of polycystic ovary syndrome","volume":"21","author":"Mehrabian","year":"2016","journal-title":"Journal of Research in Medical Sciences"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejogrb.2004.06.035","article-title":"Combined use of metformin and ethinyl estradiol-cyproterone acetate in polycystic ovary syndrome","volume":"118","author":"Mitkov","year":"2005","journal-title":"European Journal of Obstetrics and Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0074|cit74","first-page":"67","article-title":"Metabolic and endocrine effect of metformin and metformin plus cyclic dydrogestrel in women with polycystic ovarian syndrome","volume":"11","author":"Moghtadaei","year":"2009","journal-title":"Cell Journal"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0075|cit75","unstructured":"Moretti CG Guccione L di Giacinto P Cannuccia A Meleca C Lanzolla G Efficacy and safety of myo-inositol supplementation in the treatment of obese hirsute PCOS women: comparative evaluation with OCP+bicalutamide therapy Endocrine Society Journal, poster SUN-153 2016"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0076|cit76","unstructured":"The effect of OCP and Metformin on Clinical, hormonal, metabolic and ultrasonographic characteristics in PCOS clinicaltrials.gov\/show\/NCT02866786"},{"issue":"3","key":"10.1002\/14651858.CD005552.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2478\/v10153-011-0052-3","article-title":"Effect of short-term standard therapeutic regimens on neuropeptide Y and adipose tissue hormones in overweight insulin-resistant women with polycystic ovary syndrome","volume":"53","author":"Orbetzova","year":"2011","journal-title":"Folia Medica"},{"issue":"8","key":"10.1002\/14651858.CD005552.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3109\/09513590.2010.507283","article-title":"The impact of oral contraceptives and metformin on anti-M\u00fcllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia","volume":"27","author":"Panidis","year":"2011","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/bcpt.12874","article-title":"The pharmacogenetics of metformin in women with polycystic ovary syndrome: a randomized trial","volume":"122","author":"Pedersen","year":"2018","journal-title":"Basic and Clinical Pharmacology and Toxicology"},{"issue":"7","key":"10.1002\/14651858.CD005552.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.fertnstert.2009.01.114","article-title":"Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome; a randomized double-blind placebo-controlled clinical trial","volume":"93","author":"Romualdi","year":"2010","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5152\/jtgga.2016.16129","article-title":"Comparison of efficacy of metformin and oral contraceptive combination of ethinyl estradiol and drospirenone in polycystic ovary syndrome","volume":"17","author":"Suvarna","year":"2016","journal-title":"Journal of the Turkish-German Gynecological Association"},{"issue":"1","key":"10.1002\/14651858.CD005552.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.fertnstert.2008.09.034","article-title":"Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy","volume":"93","author":"Teede","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"8","key":"10.1002\/14651858.CD005552.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"883","DOI":"10.4103\/0366-6999.179783","article-title":"Comparison of drospirenone with cyproterone acetate containing oral contraceptives, combined with metformin and lifestyle modifications in women with polycystic ovary syndrome and metabolic disorders: a prospective randomized control trial","volume":"129","author":"Song","year":"2016","journal-title":"Chinese Medical Journal"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.fertnstert.2009.10.016","article-title":"Comparison of effects of 3 mg drospirenone plus 20 \u00b5g ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome","volume":"94","author":"Fruzzetti","year":"2009","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0085|cit85","unstructured":"Spremovic-Radjenovic S Sreckovic S Gudovic A Djakonovic M Bila J Radonjic-Lazovic G Comparison of the effects of dianogest\/ethinyl estradiol and metformin on metabolic parameters in non-obese women with polycystic ovary syndrome Poster, European Society of Contraception and Reproductive Health, S207 2014"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD005552.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/j.fertnstert.2010.07.248","article-title":"Addition of low dose of metformin to the oral contraceptive has no great advantage in terms of cardiovascular risk markers in women with polycystic ovary syndrome regardless insulin resistance","volume":"94","author":"Vieira","year":"2010","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0087|cit87","unstructured":"OCP vs metformin for Improvement in clinical symptoms and metabolic markers in Indian PCOS women (OCP)"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0088|cit88","unstructured":"Comparing the effects of oral contraceptive pills versus metformin (COMET-PCOS)"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0089|cit89","unstructured":"Relative desirability of metformin vs. birth control pill in treating PCOS in women of later reproductive age"},{"issue":"5","key":"10.1002\/14651858.CD005552.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"e20154089","DOI":"10.1542\/peds.2015-4089","article-title":"Metformin or oral contraceptives for adolescents with polycystic ovarian syndrome: a meta-analysis","volume":"137","author":"Al Khalifah","year":"2016","journal-title":"Peditrics"},{"issue":"5","key":"10.1002\/14651858.CD005552.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"859.e1","DOI":"10.1016\/j.jaad.2014.05.009","article-title":"Polycystic ovary syndrome: a review for dermatologists Part II. Treatment","volume":"71","author":"Buzney","year":"2014","journal-title":"Journal of the American Academy of Dermatology."},{"key":"10.1002\/14651858.CD005552.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2265.1990.tb03897.x","article-title":"Effects of luteinizing hormone, insulin, insulin-like growth factor-1 and insulin-like growth factor small binding protein-1 in the polycystic ovary syndrome","volume":"33","author":"Conway","year":"1990","journal-title":"Clinical Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD005552.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(02)04554-5","article-title":"A systematic review of the reproductive system effects of Metformin in patients with polycystic ovary syndrome","volume":"79","author":"Costello","year":"2003","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0094|cit94","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/jc.2002-021528","article-title":"A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills","volume":"88","author":"Diamanti-Kandarakis","year":"2003","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"6","key":"10.1002\/14651858.CD005552.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"981-1030","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocrine Reviews"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-2007-1016376","article-title":"Molecular mechanisms of insulin resistance in the polycystic ovary syndrome","volume":"12","author":"Dunaif","year":"1994","journal-title":"Seminars in Reproductive Endocrinology"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"The Rotterdam ESHRE\/ASRM-sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12958-017-0313-y","article-title":"Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome","volume":"15","author":"Freitas de Medeiros","year":"2017","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"8","key":"10.1002\/14651858.CD005552.pub3-BIB0102|cit102","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003989.pub5","article-title":"20 \u00b5g versus >20 \u00b5g estrogen combined oral contraceptives for contraception.","author":"Gallo","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0103|cit103","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0015-0282(98)00454-3","article-title":"Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome","volume":"71","author":"Hasegawa","year":"1999","journal-title":"Fertility and Sterility"},{"issue":"7414","key":"10.1002\/14651858.CD005552.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"557-60","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0106|cit106","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions version 5.2 (updated 2017). The Cochrane Collaboration, 2011 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/oxfordjournals.humrep.a019031","article-title":"Polycystic ovary syndrome - from gynaecological curiosity to multisystem endocrinopathy","volume":"11","author":"Homburg","year":"1996","journal-title":"Human Reproduction"},{"issue":"18","key":"10.1002\/14651858.CD005552.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2165\/00003495-200363180-00001","article-title":"Metformin: new understandings, new uses","volume":"63","author":"Hundal","year":"2003","journal-title":"Drugs"},{"issue":"6","key":"10.1002\/14651858.CD005552.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/GCO.0b013e32833e1264","article-title":"Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update","volume":"22","author":"Katsiki","year":"2010","journal-title":"Current Opinion in Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/humupd\/dmx039","article-title":"Combined oral contraceptive and\/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis","volume":"24","author":"Luque-Ramirez","year":"2018","journal-title":"Human Reproduction Update"},{"issue":"4","key":"10.1002\/14651858.CD005552.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1-25","DOI":"10.1210\/jc.2018-00241","article-title":"Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society* Clinical Practice Guideline","volume":"103","author":"Martin","year":"2018","journal-title":"Journal of Clinical and Endocrinology Metabolism"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0015-0282(02)03111-4","article-title":"Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus","volume":"77","author":"Ovalle","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0113|cit113","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0115|cit115","unstructured":"Ryan R Cochrane Consumers and Communication Review Group Cochrane Consumers and Communication Group: meta-analysis http:\/\/cccrg.cochrane.org"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Medicine"},{"issue":"9","key":"10.1002\/14651858.CD005552.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/cen.14013","article-title":"Effect of the combined oral contraceptive pill and\/or Metformin in the management of polycystique ovary syndrome: a systematic review with meta-analyses","volume":"91","author":"Teede","year":"2019","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJM199608293350909","article-title":"Insulin and the polycystic ovary syndrome","volume":"335","author":"Utiger","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/humupd\/8.3.231","article-title":"Long-term health consequences of PCOS","volume":"8","author":"Wild","year":"2002","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD005552.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1067\/mob.2002.119180","article-title":"Polycystic ovary syndrome: a risk for coronary artery disease?","volume":"186","author":"Wild","year":"2002","journal-title":"American Journal of Obstetrics & Gynaecology"},{"issue":"4","key":"10.1002\/14651858.CD005552.pub3-BIB0122|cit122","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005552","article-title":"Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne, and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome","author":"Costello","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD005552.pub3-BIB0123|cit123","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005552.pub2","article-title":"Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome","author":"Costello","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T02:35:19Z","timestamp":1675478119000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005552.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":123,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005552.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,13]]}}}